OneMedForum Recap: Del Mar Pharmaceuticals
Delmar Pharmaceuticals (DMPI) is a clinical and early stage Oncologyl Company focused on developing and commercializing leading anti-cancer therapies in high impact orphan oncological indications specifically where patients have failed contemporary therapy.
Read more »
OneMedForum Recap: Pressure Biosciences
Pressure Biosciences (PBIO) is a life sciences company centered on developing and commercializing a novel technology titled Pressure Cycling Technology (PCT).
Read more »
The Fly on the Wall: Athersys Publishes Study on Increasing Survival of Organ Transplants With Stem Cells
Athersys (ATHX) is a clinical stage based biopharmaceutical company with an exponentially growing pipeline and an array of products in therapeutics to treat significant and life-threatening diseases.
Read more »
Pharma Live: Cytokinetics amending errors in Amyotrophic Lateral Sclerosis Phase IIB Study
Cytokinetics (CYTK) is a clinical stage biotechnology company that focuses on the discovery and development of novel molecular therapeutics in relation to muscle function.
Read more »
BioCentury: Orexo is Dissolving Away Opioid Addiction with New Medication
Orexo is an emerging specialty pharmaceutical company in route to enter the market with their new medication Zubsolv; an oral medication that dissolves under the tongue to treat opioid addiction.
Read more »